The prediction is that if CTLs indeed can secrete IFN-γ and TNFα to sensitize the tumor cells, then combinational therapy of CTL adoptive transfer and TRAIL therapy should exhibit greater anti-tumor efficacy than CTL or TRAIL alone. This evidence concerns the gene IFNG and neoplasm.